Shares of Evoke plc (LON:EVOK – Get Free Report) dropped 10% during trading on Thursday . The company traded as low as GBX 50.20 ($0.65) and last traded at GBX 51.73 ($0.67). Approximately 65,066,164 shares were traded during mid-day trading, an increase of 1,994% from the average daily volume of 3,107,171 shares. The stock had previously closed at GBX 57.45 ($0.74).
Analyst Ratings Changes
Several research firms have recently weighed in on EVOK. Jefferies Financial Group restated a “buy” rating and set a GBX 140 ($1.81) price objective on shares of Evoke in a research report on Monday, December 16th. Berenberg Bank reduced their target price on shares of Evoke from GBX 130 ($1.68) to GBX 90 ($1.16) and set a “buy” rating on the stock in a report on Wednesday, December 4th.
View Our Latest Report on Evoke
Evoke Stock Performance
Evoke (LON:EVOK – Get Free Report) last issued its quarterly earnings data on Wednesday, March 26th. The company reported GBX (6.40) (($0.08)) EPS for the quarter. Evoke had a negative return on equity of 517.98% and a negative net margin of 8.50%. Equities analysts anticipate that Evoke plc will post 12.7648305 earnings per share for the current fiscal year.
Insiders Place Their Bets
In other Evoke news, insider Andrea Gisle Joosen purchased 14,572 shares of the firm’s stock in a transaction that occurred on Tuesday, January 28th. The stock was bought at an average cost of GBX 70 ($0.91) per share, for a total transaction of £10,200.40 ($13,202.69). Company insiders own 27.00% of the company’s stock.
Evoke Company Profile
See Also
- Five stocks we like better than Evoke
- Health Care Stocks Explained: Why You Might Want to Invest
- MarketBeat Week in Review – 03/24 – 03/28
- Are Penny Stocks a Good Fit for Your Portfolio?
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- 4 Healthcare Stocks With Massive Gains—and More to Come
Receive News & Ratings for Evoke Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evoke and related companies with MarketBeat.com's FREE daily email newsletter.